Hudson Bay Capital Management »

Apellis Pharmaceuticals shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.1M 35k 58.78
2023-09-30 $476k 13k 38.04
2023-03-31 $3.3M 50k 65.96
2020-09-30 $1.8M 60k 30.17

More positions owned by Hudson Bay Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Put Option (MSFT)
NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A Put Option (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Put Option (TSLA)
Advanced Micro Devices Put Option (AMD)
Ishares Tr Msci Acwi Etf Put Option (ACWI)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Pioneer Natural Resources Put Option (PXD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)

View all positions for Hudson Bay Capital Management

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
BlackRock
T. Rowe Price Investment Management
Jennison Associates
Octagon Capital Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
FMR
Assenagon Asset Management
Boxer Capital
Geode Capital Management
Morgan Stanley

View all funds holding Apellis Pharmaceuticals